Literature DB >> 28724574

The microvascular niche instructs T cells in large vessel vasculitis via the VEGF-Jagged1-Notch pathway.

Zhenke Wen1, Yi Shen1, Gerald Berry2, Farhad Shahram1, Yinyin Li1, Ryu Watanabe1, Yaping Joyce Liao3, Jörg J Goronzy1, Cornelia M Weyand4.   

Abstract

Microvascular networks in the adventitia of large arteries control access of inflammatory cells to the inner wall layers (media and intima) and thus protect the immune privilege of the aorta and its major branches. In autoimmune vasculitis giant cell arteritis (GCA), CD4 T helper 1 (TH1) and TH17 cells invade into the wall of the aorta and large elastic arteries to form tissue-destructive granulomas. Whether the disease microenvironment provides instructive cues for vasculitogenic T cells is unknown. We report that adventitial microvascular endothelial cells (mvECs) perform immunoregulatory functions by up-regulating the expression of the Notch ligand Jagged1. Vascular endothelial growth factor (VEGF), abundantly present in GCA patients' blood, induced Jagged1 expression, allowing mvECs to regulate effector T cell induction via the Notch-mTORC1 (mammalian target of rapamycin complex 1) pathway. We found that circulating CD4 T cells in GCA patients have left the quiescent state, actively signal through the Notch pathway, and differentiate into TH1 and TH17 effector cells. In an in vivo model of large vessel vasculitis, exogenous VEGF functioned as an effective amplifier to recruit and activate vasculitogenic T cells. Thus, systemic VEGF co-opts endothelial Jagged1 to trigger aberrant Notch signaling, biases responsiveness of CD4 T cells, and induces pathogenic effector functions. Adventitial microvascular networks function as an instructive tissue niche, which can be exploited to target vasculitogenic immunity in large vessel vasculitis.
Copyright © 2017 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28724574      PMCID: PMC5708299          DOI: 10.1126/scitranslmed.aal3322

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN: 1946-6234            Impact factor:   17.956


  79 in total

Review 1.  Transcriptional regulation of innate and adaptive lymphocyte lineages.

Authors:  Maria Elena De Obaldia; Avinash Bhandoola
Journal:  Annu Rev Immunol       Date:  2015-02-04       Impact factor: 28.527

Review 2.  Does senescence affect lymph node number and morphology? A systematic review.

Authors:  Omid Ahmadi; John L McCall; Mark D Stringer
Journal:  ANZ J Surg       Date:  2013-01-25       Impact factor: 1.872

3.  Selective up-regulation of the soluble pattern-recognition receptor pentraxin 3 and of vascular endothelial growth factor in giant cell arteritis: relevance for recent optic nerve ischemia.

Authors:  Mattia Baldini; Norma Maugeri; Giuseppe A Ramirez; Chiara Giacomassi; Alessandra Castiglioni; Sergio Prieto-González; Marc Corbera-Bellalta; Gabriele Di Comite; Ilenia Papa; Giacomo Dell'antonio; Enrico Ammirati; Ivan Cuccovillo; Viviana Vecchio; Alberto Mantovani; Patrizia Rovere-Querini; Maria Grazia Sabbadini; Maria C Cid; Angelo A Manfredi
Journal:  Arthritis Rheum       Date:  2012-03

Review 4.  The spectrum of giant cell arteritis and polymyalgia rheumatica: revisiting the concept of the disease.

Authors:  Christian Dejaco; Christina Duftner; Frank Buttgereit; Eric L Matteson; Bhaskar Dasgupta
Journal:  Rheumatology (Oxford)       Date:  2017-04-01       Impact factor: 7.580

5.  Functional profile of tissue-infiltrating and circulating CD68+ cells in giant cell arteritis. Evidence for two components of the disease.

Authors:  A D Wagner; J J Goronzy; C M Weyand
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

6.  NADPH oxidase deficiency underlies dysfunction of aged CD8+ Tregs.

Authors:  Zhenke Wen; Yasuhiro Shimojima; Tsuyoshi Shirai; Yinyin Li; Jihang Ju; Zhen Yang; Lu Tian; Jörg J Goronzy; Cornelia M Weyand
Journal:  J Clin Invest       Date:  2016-04-18       Impact factor: 14.808

7.  Vessel-specific Toll-like receptor profiles in human medium and large arteries.

Authors:  Olga Pryshchep; Wei Ma-Krupa; Brian R Younge; Jörg J Goronzy; Cornelia M Weyand
Journal:  Circulation       Date:  2008-09-02       Impact factor: 29.690

8.  Restoring oxidant signaling suppresses proarthritogenic T cell effector functions in rheumatoid arthritis.

Authors:  Zhen Yang; Yi Shen; Hisashi Oishi; Eric L Matteson; Lu Tian; Jörg J Goronzy; Cornelia M Weyand
Journal:  Sci Transl Med       Date:  2016-03-23       Impact factor: 17.956

9.  Another TLO in the Wall: Education and Control of T Cells in Atherosclerotic Arteries.

Authors:  Lucas Onder; Burkhard Ludewig
Journal:  Immunity       Date:  2015-06-16       Impact factor: 31.745

10.  Lymphotoxin beta receptor signaling promotes tertiary lymphoid organogenesis in the aorta adventitia of aged ApoE-/- mice.

Authors:  Rolf Gräbner; Katharina Lötzer; Sandra Döpping; Markus Hildner; Dörte Radke; Michael Beer; Rainer Spanbroek; Beatrix Lippert; Catherine A Reardon; Godfrey S Getz; Yang-Xin Fu; Thomas Hehlgans; Reina E Mebius; Michael van der Wall; Dagmar Kruspe; Christoph Englert; Agnes Lovas; Desheng Hu; Gwendalyn J Randolph; Falk Weih; Andreas J R Habenicht
Journal:  J Exp Med       Date:  2009-01-12       Impact factor: 14.307

View more
  33 in total

1.  Vasculitis syndromes: Notch one up for the endothelium.

Authors:  Joanna Collison
Journal:  Nat Rev Rheumatol       Date:  2017-08-10       Impact factor: 20.543

2.  CD28 Signaling Controls Metabolic Fitness of Pathogenic T Cells in Medium and Large Vessel Vasculitis.

Authors:  Hui Zhang; Ryu Watanabe; Gerald J Berry; Steven G Nadler; Jörg J Goronzy; Cornelia M Weyand
Journal:  J Am Coll Cardiol       Date:  2019-04-16       Impact factor: 24.094

Review 3.  The immunoinhibitory PD-1/PD-L1 pathway in inflammatory blood vessel disease.

Authors:  Cornelia M Weyand; Gerald J Berry; Jörg J Goronzy
Journal:  J Leukoc Biol       Date:  2017-12-29       Impact factor: 4.962

4.  Inhibition of JAK-STAT Signaling Suppresses Pathogenic Immune Responses in Medium and Large Vessel Vasculitis.

Authors:  Hui Zhang; Ryu Watanabe; Gerald J Berry; Lu Tian; Jörg J Goronzy; Cornelia M Weyand
Journal:  Circulation       Date:  2017-12-18       Impact factor: 29.690

5.  Cytokines, growth factors and proteases in medium and large vessel vasculitis.

Authors:  Cornelia M Weyand; Ryu Watanabe; Hui Zhang; Mitsuhiro Akiyama; Gerald J Berry; Jörg J Goronzy
Journal:  Clin Immunol       Date:  2019-02-14       Impact factor: 3.969

6.  MMP (Matrix Metalloprotease)-9-Producing Monocytes Enable T Cells to Invade the Vessel Wall and Cause Vasculitis.

Authors:  Ryu Watanabe; Toshihisa Maeda; Hui Zhang; Gerald J Berry; Markus Zeisbrich; Robert Brockett; Andrew E Greenstein; Lu Tian; Jörg J Goronzy; Cornelia M Weyand
Journal:  Circ Res       Date:  2018-08-31       Impact factor: 17.367

7.  Cervical Cytokines Associated With Chlamydia trachomatis Susceptibility and Protection.

Authors:  Taylor B Poston; De'Ashia E Lee; Toni Darville; Wujuan Zhong; Li Dong; Catherine M O'Connell; Harold C Wiesenfeld; Sharon L Hillier; Gregory D Sempowski; Xiaojing Zheng
Journal:  J Infect Dis       Date:  2019-06-19       Impact factor: 5.226

Review 8.  Vasculitogenic T Cells in Large Vessel Vasculitis.

Authors:  Ryu Watanabe; Motomu Hashimoto
Journal:  Front Immunol       Date:  2022-06-15       Impact factor: 8.786

9.  NOTCH-induced rerouting of endosomal trafficking disables regulatory T cells in vasculitis.

Authors:  Ke Jin; Zhenke Wen; Bowen Wu; Hui Zhang; Jingtao Qiu; Yanan Wang; Kenneth J Warrington; Gerald J Berry; Jorg J Goronzy; Cornelia M Weyand
Journal:  J Clin Invest       Date:  2021-01-04       Impact factor: 14.808

Review 10.  Pathogenesis of Giant Cell Arteritis and Takayasu Arteritis-Similarities and Differences.

Authors:  Ryu Watanabe; Gerald J Berry; David H Liang; Jörg J Goronzy; Cornelia M Weyand
Journal:  Curr Rheumatol Rep       Date:  2020-08-26       Impact factor: 4.686

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.